Inmunotek S.l.
Clinical trials sponsored by Inmunotek S.l., explained in plain language.
-
Can a 5-Year allergy shot regimen tame severe dust mite reactions?
Disease control CompletedThis study looked back at the real-world use of a specific allergy shot treatment for people allergic to dust mites. Researchers analyzed data from 140 patients, aged 5 to 65, who received the shots for at least one year to see if their allergy and asthma symptoms and medication …
Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Apr 02, 2026 05:42 UTC
-
Spray vaccine shows promise in taming COPD flare-ups
Disease control CompletedThis study tested whether a daily under-the-tongue spray called MV130 could help adults with moderate to severe COPD. The goal was to see if this bacterial vaccine could reduce the number and severity of sudden worsening episodes (exacerbations) that people with COPD experience. …
Phase: PHASE2, PHASE3 • Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Scientists pinpoint skin reaction strength for common grass allergies
Knowledge-focused CompletedThis study aimed to measure how strongly two common grass pollen extracts cause a skin reaction in people with allergies, compared to a standard histamine solution. Thirty-one adults with confirmed grass pollen allergies participated in a single visit where they received small sk…
Phase: NA • Sponsor: Inmunotek S.L. • Aim: Knowledge-focused
Last updated Mar 17, 2026 12:55 UTC